Chenguang Biotech Group (300138.SZ) issues a profit warning, expecting a net profit of 80-115 million yuan for the year, a year-on-year decrease of 76.03% to 83.32%.

Chenguang Biotech Group (300138.SZ) disclosed its performance forecast for 2024, with the company expecting a net profit attributable to shareholders of the listed company of 80 million to 115 million yuan, a year-on-year decrease of 76.03% to 83.32%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses is expected to be 20 million to 55 million yuan, a year-on-year decrease of 85.02% to 94.55%.